Financial PerformanceAT&S reported FY Q1 with sales of €349m and adj. EBITDA of €97m, beating consensus by 20% on adj. EBITDA level.
Long-term GrowthLong-term growth for AT&S is expected to be driven by rising IC substrate penetration in AI/HPC and smartphone applications, with an anticipated CAGR of 25% from 2024 to 2027.
Strategic MovesAT&S dropped its plans to do a rights issue and will sell a plant that manufactures products for the medical market, generating EBITDA of €38m last FY.